Matrix metalloproteinase expression in cytokine stimulated human dermal fibroblasts.

[1]  J. Reynolds,et al.  Collagenases and tissue inhibitors of metalloproteinases: a functional balance in tissue degradation. , 2008, Oral diseases.

[2]  T. Hsiao,et al.  Matrix Metalloproteinase-1 and Tissue Inhibitor of Metalloproteinase-1 Gene Expressions and Their Differential Regulation by Proinflammatory Cytokines and Prostaglandin in Nasal Polyp Fibroblasts , 2001, The Annals of otology, rhinology, and laryngology.

[3]  V. Kähäri,et al.  Matrix metalloproteinases in wound repair (review). , 2000, International journal of molecular medicine.

[4]  T. Tsuji,et al.  Alterations of extracellular matrix induced by tobacco smoke extract , 2000, Archives of Dermatological Research.

[5]  S. Santavirta,et al.  Analysis of 16 different matrix metalloproteinases (MMP-1 to MMP-20) in the synovial membrane: different profiles in trauma and rheumatoid arthritis , 1999, Annals of the rheumatic diseases.

[6]  M. Varedi,et al.  A thermal injury-induced circulating factor(s) compromises intestinal cell morphology, proliferation, and migration. , 1999, American journal of physiology. Gastrointestinal and liver physiology.

[7]  S. Loening,et al.  Analytical aspects regarding the measurement of metalloproteinases and their inhibitors in blood. , 1997, Clinical biochemistry.

[8]  E. Waelti,et al.  Autologous Versus Allogeneic T Cell-Stimulated IL-6 Production by Dermal Fibroblasts , 1997, Inflammation.

[9]  E. Waelti,et al.  Juxtacrine stimulation of cytokine production in cocultures of human dermal fibroblasts and T cells. , 1996, Cytokine.

[10]  E. Fireman,et al.  Effect of IL-6 on alveolar fibroblast proliferation in interstitial lung diseases. , 1996, Clinical immunology and immunopathology.

[11]  S. Pahwa,et al.  Augmented interleukin-6 secretion in collagen-stimulated peripheral blood mononuclear cells from patients with systemic sclerosis. , 1994, Annals of allergy.

[12]  A. Mauviel.  Cytokine regulation of metalloproteinase gene expression , 1993, Journal of cellular biochemistry.

[13]  M. Yoshida,et al.  Plasma tumour necrosis factor-α (TNF-α) levels in patients with burns , 1993 .

[14]  F. Schildberg,et al.  Functional analysis of monocyte activity through synthesis patterns of proinflammatory cytokines and neopterin in patients in surgical intensive care. , 1992, Surgery.

[15]  K. Bost,et al.  Mechanisms of pathogenesis in scleroderma. I. Overproduction of interleukin 6 by fibroblasts cultured from affected skin sites of patients with scleroderma. , 1992, The Journal of rheumatology.

[16]  J. Woessner,et al.  Matrix metalloproteinases and their inhibitors in connective tissue remodeling , 1991, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[17]  J. Watson,et al.  Expression of the interleukin 6 gene in rheumatoid synovial fibroblasts. , 1990, The Journal of rheumatology.

[18]  J. Rosenbloom,et al.  Cytokine networks in the regulation of inflammation and fibrosis in the lung. , 1990, Chest.

[19]  A. Schönthal,et al.  Requirement for fos gene expression in the transcriptional activation of collagenase by other oncogenes and phorbol esters , 1988, Cell.

[20]  C. Hack,et al.  SERUM LEVELS OF INTERLEUKIN-6 AND ACUTE PHASE RESPONSES , 1987, The Lancet.

[21]  M. Sano,et al.  Research Paper Mediators of Inflammation, 9, 155–160 (2000) , 2022 .

[22]  P. Courtoy,et al.  Local cytokines induce differential expression of matrix metalloproteinases but not their tissue inhibitors in human endometrial fibroblasts. , 1999, European journal of biochemistry.

[23]  H. Nagase.  Matrix metalloproteinases. A mini-review. , 1994, Contributions to nephrology.

[24]  K. Bost,et al.  Control of IL-6 expression and response in fibroblasts from patients with systemic sclerosis. , 1994, Autoimmunity.

[25]  S. Twining.  Regulation of proteolytic activity in tissues. , 1994, Critical reviews in biochemistry and molecular biology.